Quanterix Corporation

QTRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.17

+$0.13 (+4.28%)

Sep 22, 2026, 1:24 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+4.28%

(1D)

Rating

Updated: Aug 15, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $149.33M

1D Range

3.03 3.21

52W Range

2.15 8.77

Valuation (TTM)

PE -1.16

PB 0.60

EV/EBITDA -0.78

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target $3

Cash Flow

FCF Yield -51.7%

SBC Adj. FCF Yield -60.8%

SBC Impact -17.8%

Margins

Gross Margin 42.6%

Operating Margin -86.2%

FCF Margin -48.3%

Growth (CAGR)

Revenue 3Y | 5Y 11.3% | 7.2%

Dil EPS 3Y | 5Y -45.2% | -5.5%

FCF 3Y | 5Y -34.4% | -2.9%

Returns

ROA -38.5%

ROE -43.6%

ROIC -46.9%

Financial Health

Net Cash

$60.14M

Current Ratio 3.40

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems ...

Sector Healthcare

Industry Medical - Devices

Employees 450

IPO Date Dec 6, 2017

Website www.quanterix.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Downside

-5.36%

Buy (0)

Hold (2)

Sell (0)

Analyst Details ➞